| Original language | English |
|---|---|
| Pages (from-to) | 21-24 |
| Number of pages | 4 |
| Journal | Clinical Microbiology and Infection |
| Volume | 14 |
| Issue number | SUPPL. 5 |
| DOIs |
|
| Publication status | Published - May 2008 |
Bibliographical note
Funding Information:MG declares no conflict of interest regarding this publication and acknowledges support from the European Union for his work in the field of β-lactamases.
Funding Information:
GMR, MMD and CM affirm that there are no conflicts of interest concerning the ideas expressed in this paper. All authors acknowledge research grants from the European Commision, the Italian Ministry of Research and University, and Wyeth Pharmaceuticals.
Funding Information:
RC has received grants from Wyeth and Sanofi Aventis and consultancy fees from Novartis; he declares no conflicting or dual interests concerning this paper. AN, AV, EM, LP, FB and TMC declare no conflicting or dual interests in relation to the work or opinions presented in this paper. All authors acknowledge funding support from the Ministerio de Sanidad y Consumo and Ministerio de Ciencia y Tecnologia, Spain and from the European Union.
Funding Information:
PMH acknowledges support from the British Society for Antimicrobial Therapy, British Council, University Grant Commission, India, the Royal Thai Government, Merck and Wyeth for work undertaken.
Funding Information:
MA acknowledges reserach funding from Merck Sharp and Dohme and Pfizer, speaker fees from Wyeth and Pfizer, and travel grants from Merck Sharp and Dohme, Wyeth, Sanofi-Aventis and Pfizer, including a grant to attend the meeting at which this paper was presented; he declares no conflict of interest concerning the views expressed.
Funding Information:
HG has received consulting fees from Wyeth as well as research grants from Elli–Lilly, Sanofi–Aventis, Abbott, Pfizer and Novartis, independant of the topic of this paper, and declares no conflict of interest.
